2. In findings section of the abstract, it is more useful to include the genus/species of host, and leave the accession numbers to the methods section. Additionally, it would be more useful to include Gb data produced, as well as the size of the genome, upfront. 3. In table 1, please make yes/no capitalization consistent. A label of some kind linking the workflows in Fig  1 and Fig 2 and 3 -or linking to the Table would be very helpful. Many different preparations are represented here, and parsing them in the current format is challenging at best. Perhaps some sort of encoding like ONT-cDNA-polyA_1 at the bottom of fig 3 for the relevant workflow and labeled as a column in Table 1? Additionally, please make clear for fig 3 what is dRNA and what is cDNA. 4. Sometimes you denote 5'/3', sometimes 5′/3′, please make consistent to 5′/3′. 5. All of your figures should have y-axis labels and, in the case of figures 4 and 7 -a legend explaining the colors. 6. Please add "availability of source code and requirements" as per https://academic.oup.com/gigascience/pages/data_note 7. Standard deviance should be changed to standard deviation. 8. The statement in line 235 "These aligned reads can be further analyzed by using different long read aligners" should be modified to "These aligned reads can be further analyzed by comparing to results of different long read aligners" 9. Alignment file names should be updated to a consistent format 10. Tables 3 and 5 should be combined. 11. Table 1 and Figure 1 are redundant, consider removing Figure 1 or adding additional unique information to it. 12. Your text mentions a "fast5.tar.gz" file for ONT dRNA, but listed in the dRNA folder of archives is just a "tar.gz" file in addition to the BAMs -please clarify that this is the same. Also, you only included the raw reads which aligned to VCAV -but it is worthwhile to include all reads as well, because your alignments might not be all-inclusive. 13. What size is the tissue culture flask for the CV-1s? 14. Why were 3x freeze-thaw cycles applied? What is the reasoning for that?
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